Corbus Pharmaceuticals Holdings (CRBP) Accounts Payables (2013 - 2025)

Corbus Pharmaceuticals Holdings' Accounts Payables history runs 13 years deep, the most recent figure standing at $2.2 million for Q4 2025.

• In Q4 2025, Accounts Payables fell 53.72% year-over-year to $2.2 million; the TTM figure through Dec 2025 stood at $2.2 million (down 53.72% YoY), while the FY2025 annual figure was $2.2 million, down 53.72% from the prior year.
• Accounts Payables was $2.2 million for Q4 2025 at Corbus Pharmaceuticals Holdings, down from $2.7 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $4.8 million in Q4 2024 to a low of $1.2 million in Q2 2024.
• Historically, Accounts Payables has averaged $2.6 million across 5 years, with a median of $2.4 million in 2021.
• The sharpest annual moves came in 2021 and 2025: Accounts Payables tumbled 85.21% in 2021, then surged 246.18% in 2025.
• A 5-year view of Accounts Payables shows it stood at $1.8 million in 2021, then rose by 21.98% to $2.2 million in 2022, then surged by 46.23% to $3.2 million in 2023, then jumped by 50.55% to $4.8 million in 2024, then tumbled by 53.72% to $2.2 million in 2025.
• The last three Accounts Payables figures came in at $2.2 million (Q4 2025), $2.7 million (Q3 2025), and $4.0 million (Q2 2025), per Business Quant data.